Trial · NCT02002884
Results by group252
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 252
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| MP: Change From Baseline in Ashworth Scale (AS) in UL Primary Clinical Target Pattern at Week 4 | MP Low Dose Group | High versus low | -0.93 | Standard Error 0.078 | Unit on a scale |
| MP: Change From Baseline in Ashworth Scale (AS) in UL Primary Clinical Target Pattern at Week 4 | MP High Dose Group | High versus low | -1.15 | Standard Error 0.056 | Unit on a scale |
| MP: Change From Baseline in Ashworth Scale (AS) in UL Primary Clinical Target Pattern at Week 4 | MP Low Dose Group | Mid versus low | -0.96 | Standard Error 0.082 | Unit on a scale |
| MP: Change From Baseline in Ashworth Scale (AS) in UL Primary Clinical Target Pattern at Week 4 | MP Mid Dose Group | Mid versus low | -1.02 | Standard Error 0.082 | Unit on a scale |
| Co-primary Variable MP: Investigator's Global Impression of Change Scale (GICS) at Week 4 | MP Low Dose Group | High versus low | 1.55 | Standard Error 0.083 | Unit on a scale |
| Co-primary Variable MP: Investigator's Global Impression of Change Scale (GICS) at Week 4 | MP High Dose Group | High versus low | 1.64 | Standard Error 0.062 | Unit on a scale |
| Co-primary Variable MP: Investigator's Global Impression of Change Scale (GICS) at Week 4 | MP Low Dose Group | Mid versus low | 1.57 | Standard Error 0.089 | Unit on a scale |
| Co-primary Variable MP: Investigator's Global Impression of Change Scale (GICS) at Week 4 | MP Mid Dose Group | Mid versus low | 1.44 | Standard Error 0.092 | Unit on a scale |
| MP: Change From Baseline in AS Score of the Other Treated UL Main Clinical Target Pattern at Week 4 | MP Low Dose Group | High versus low | -1.03 | Standard Error 0.083 | Unit on a scale |
| MP: Change From Baseline in AS Score of the Other Treated UL Main Clinical Target Pattern at Week 4 | MP High Dose Group | High versus low | -1.13 | Standard Error 0.061 | Unit on a scale |
| MP: Change From Baseline in AS Score of the Other Treated UL Main Clinical Target Pattern at Week 4 | MP Low Dose Group | Mid versus low | -1.08 | Standard Error 0.087 | Unit on a scale |
| MP: Change From Baseline in AS Score of the Other Treated UL Main Clinical Target Pattern at Week 4 | MP Mid Dose Group | Mid versus low | -1.22 | Standard Error 0.090 | Unit on a scale |
| MP: Change From Baseline in AS Score in UL Treated Clenched Fist With Flexed Wrist at Week 4 | MP Low Dose Group | High versus low | -0.53 | Standard Error 0.212 | Unit on a scale |
| MP: Change From Baseline in AS Score in UL Treated Clenched Fist With Flexed Wrist at Week 4 | MP High Dose Group | High versus low | -1.00 | Standard Error 0.133 | Unit on a scale |
| MP: Change From Baseline in AS Score in UL Treated Clenched Fist With Flexed Wrist at Week 4 | MP Low Dose Group | Mid versus low | -0.070 | Standard Error 0.202 | Unit on a scale |
| MP: Change From Baseline in AS Score in UL Treated Clenched Fist With Flexed Wrist at Week 4 | MP Mid Dose Group | Mid versus low | -1.04 | Standard Error 0.176 | Unit on a scale |
| MP: Change From Baseline in AS Score for Each Treated Clinical Pattern of the UL at Week 4 | MP Low Dose Group | Flexed elbow: High versus Low | -0.99 | Standard Error 0.076 | Unit on a scale |
| MP: Change From Baseline in AS Score for Each Treated Clinical Pattern of the UL at Week 4 | MP High Dose Group | Flexed elbow: High versus Low | -1.18 | Standard Error 0.056 | Unit on a scale |
| MP: Change From Baseline in AS Score for Each Treated Clinical Pattern of the UL at Week 4 | MP Low Dose Group | Flexed elbow: Mid versus Low | -1.01 | Standard Error 0.081 | Unit on a scale |
| MP: Change From Baseline in AS Score for Each Treated Clinical Pattern of the UL at Week 4 | MP Mid Dose Group | Flexed elbow: Mid versus Low | -1.17 | Standard Error 0.082 | Unit on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02002884/results